This study investigated the effects of Galileo Therapy on muscle function and lung function of adult Cystic Fibrosis (CF) patients (age 24-47). CF is a genetic disorder that typically effects the lungs for example by difficulty of breathing because of coughing up mucus. The patients received Galileo Therapy over a period of 3 Months, 2 times per day, 5 days per week, 3*3 minutes at high frequencies (20 to 25Hz).
The results of the Galileo Therapy show significant improvements of lung function by +5% (FEV, forced expiratory volume) and muscle function e.g. in the chair rising test (CRT) by +16% in muscle power and +34% in muscle force. The results of this study are in line with results of Galileo Therapy in COPD (Chronic Obstructive Pulmonary Disease, #GRFS107, #GRFS41, #GRFS34, #GRFS32) and show once more the enormous potential of Galileo as a therapy device.
#GRFS120 # GalileoTherapy #CysticFibrosis #CF #LungFunction #MuscleFunction #CRT #COPD
- 18.09.2023
- Produktgruppen: Galileo Therapy
- Themen: Back Pain, Basics, Diseases, Geriatrics, Health Promotion at Work, Incontience, Medical Applications, Neurological Conditions, Orthopedic Diseases, Osteoporosis, Paediatrics, Prevention, Pyhsitherapy & Rehabilitation, SCI, Stroke, Therapy & Prevention using Galileo, Training & Education
